Matrix metalloproteinase 7 is associated with symptomatic lesions and adverse events in patients with carotid atherosclerosis

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Abbas, Azhar ^a   Aukrust, Pål ^a,b,c   Russell, David ^a,c   Krohg Sørensen, Kirsten ^a   Almås, Trine ^d   Bundgaard, Dorte ^d   Bjerkeli, Vigdis ^a,c   Sagen, Ellen Lund ^a,c   Michelsen, Annika E ^a,c   Dahl, Tuva B ^a,c   Holm, Sverre ^a   Ueland, Thor ^a,c   Skjelland, Mona ^a   Halvorsen, Bente ^a,c  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d Østfold Hospital Trust   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

MATRILYSIN; MESSENGER RNA; OXIDIZED LOW DENSITY LIPOPROTEIN; TUMOR NECROSIS FACTOR ALPHA;

AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CAROTID ATHEROSCLEROSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME BLOOD LEVEL; ENZYME LOCALIZATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MONOCYTE; MORTALITY; PROGNOSIS; PROTEIN EXPRESSION; SYMPTOMATOLOGY;

AGED; CAROTID ARTERY DISEASES; CAROTID STENOSIS; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION; HUMANS; MALE; MATRIX METALLOPROTEINASE 7; MIDDLE AGED; MONOCYTES; PLAQUE, ATHEROSCLEROTIC; PROGNOSIS; RISK FACTORS;

EID: 84896461224     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084935     Document Type: Article

References (19)

1. Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352: 1685-1695.
2. Hansson GK, Robertson AK, Soderberg-Naucler C (2006) Inflammation and atherosclerosis. Annu Rev Pathol 1: 297-329.
3. Weber C, Noels H (2011) Atherosclerosis: current pathogenesis and therapeutic options. Nat Med 17: 1410-1422.
4. Halvorsen B, Otterdal K, Dahl TB, Skjelland M, Gullestad L, et al. (2008) Atherosclerotic plaque stability-what determines the fate of a plaque? Prog Cardiovasc Dis 51: 183-194.
5. Newby AC (2012) Matrix metalloproteinase inhibition therapy for vascular diseases. Vascul Pharmacol 56: 232-244.
6. Nagase H, Visse R, Murphy G (2006) Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 69: 562-573. (Pubitemid 43139720)
7. Pelisek J, Rudelius M, Zepper P, Poppert H, Reeps C, et al. (2009) Multiple biological predictors for vulnerable carotid lesions. Cerebrovasc Dis 28: 601-610.
8. Sapienza P, Borrelli V, di ML, Cavallaro A (2009) MMP and TIMP alterations in asymptomatic and symptomatic severe recurrent carotid artery stenosis. Eur J Vasc Endovasc Surg 37: 525-530.
9. Chen F, Eriksson P, Hansson GK, Herzfeld I, Klein M, et al. (2005) Expression of matrix metalloproteinase 9 and its regulators in the unstable coronary atherosclerotic plaque. Int J Mol Med 15: 57-65.
10. Halpert I, Sires UI, Roby JD, Potter-Perigo S, Wight TN, et al. (1996) Matrilysin is expressed by lipid-laden macrophages at sites of potential rupture in atherosclerotic lesions and localizes to areas of versican deposition, a proteoglycan substrate for the enzyme. Proc Natl Acad Sci U S A 93: 9748-9753. (Pubitemid 26296680)
11. Dahl TB, Yndestad A, Skjelland M, Oie E, Dahl A, et al. (2007) Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization. Circulation 115: 972-980. (Pubitemid 46328290)
12. Grant EG, Benson CB, Moneta GL, Alexandrov AV, Baker JD, et al. (2003) Carotid artery stenosis: gray-scale and Doppler US diagnosis-Society of Radiologists in Ultrasound Consensus Conference. Radiology 229: 340-346. (Pubitemid 37310815)
13. European Carotid Plaque Study Group (1995) Carotid artery plaque composition-relationship to clinical presentation and ultrasound B-mode imaging. European Carotid Plaque Study Group. Eur J Vasc Endovasc Surg 10: 23-30.
14. Stylianou E, Aukrust P, Muller F, Nordoy I, Froland SS (2001) Complex effects of interferon-alpha on the cytokine network in HIV infection-possible contribution to immunosuppression. Cytokine 14: 56-62. (Pubitemid 32579273)
15. Halvorsen B, Aas UK, Kulseth MA, Drevon CA, Christiansen EN, et al. (1998) Proteoglycans in macrophages: characterization and possible role in the cellular uptake of lipoproteins. Biochem J 331 (Pt 3): 743-752. (Pubitemid 28211895)
16. Furman C, Copin C, Kandoussi M, Davidson R, Moreau M, et al. (2004) Rosuvastatin reduces MMP-7 secretion by human monocyte-derived macrophages: potential relevance to atherosclerotic plaque stability. Atherosclerosis 174: 93-98. (Pubitemid 38595445)
17. Hemingway H, Philipson P, Chen R, Fitzpatrick NK, Damant J, et al. (2010) Evaluating the quality of research into a single prognostic biomarker: a systematic review and meta-analysis of 83 studies of C-reactive protein in stable coronary artery disease. PLoS Med 7: e1000286.
18. Razuvaev A, Ekstrand J, Folkersen L, Agardh H, Markus D, et al. (2011) Correlations between clinical variables and gene-expression profiles in carotid plaque instability. Eur J Vasc Endovasc Surg 42: 722-730.
19. Williams H, Johnson JL, Jackson CL, White SJ, George SJ (2010) MMP-7 mediates cleavage of N-cadherin and promotes smooth muscle cell apoptosis. Cardiovasc Res 87: 137-146.